United States · Bill · HR
H.R. 1083 (109th)
Methamphetamine Reduction Act of 2005
Introduced
3 March 2005
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sponsors
—
Subjects
Discovery layer
Source updated
15 August 2025
Summary
Methamphetamine Reduction Act of 2005 - Requires ephedrine alkaloids, including ephedrine and pseudoephedrine, to be listed in schedule V (drugs or other substances having a low potential for abuse, that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence) of the Controlled Substances Act. Excepts ephedrine alkaloid when contained in a drug that: (1) is marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act; and (2) cannot be easily used in the illicit production of methamphetamine. Provides that an ephedrine alkaloid when so contained shall be considered a listed chemical.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 3 March 2005
Introduced in House (PDF)
Introduced in House · EN · 3 March 2005
Introduced in House
summary · EN · 3 March 2005
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/house-bill/1083
- Open data entity: https://api.congress.gov/v3/bill/109/hr/1083